Genexine Stock Last Dividend Paid
| 095700 Stock | KRW 5,650 30.00 0.53% |
Genexine fundamentals help investors to digest information that contributes to Genexine's financial success or failures. It also enables traders to predict the movement of Genexine Stock. The fundamental analysis module provides a way to measure Genexine's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Genexine stock.
Genexine |
Genexine Company Last Dividend Paid Analysis
Genexine's Last Dividend Paid refers to dividend per share(DPS) paid to the shareholder the last time dividends were issued by a company. In its conventional sense, dividends refer to the distribution of some of a company's net earnings or capital gains decided by the board of directors.
More About Last Dividend Paid | All Equity Analysis
Last Dividend | = | Last Profit Distribution AmountTotal Shares |
Many stable companies today pay out dividends to their shareholders in the form of the income distribution, but high-growth firms rarely offer dividends because all of their earnings are reinvested back to the business.
| Competition |
Based on the recorded statements, Genexine has a Last Dividend Paid of 0.0. This indicator is about the same for the Biotechnology average (which is currently at 0.0) sector and about the same as Health Care (which currently averages 0.0) industry. This indicator is about the same for all Republic of Korea stocks average (which is currently at 0.0).
Genexine Last Dividend Paid Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Genexine's direct or indirect competition against its Last Dividend Paid to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Genexine could also be used in its relative valuation, which is a method of valuing Genexine by comparing valuation metrics of similar companies.Genexine is currently under evaluation in last dividend paid category among its peers.
Genexine Fundamentals
| Return On Equity | -10.06 | |||
| Return On Asset | -0.0172 | |||
| Profit Margin | 0.01 % | |||
| Operating Margin | (0.41) % | |||
| Current Valuation | 2.14 T | |||
| Shares Outstanding | 20.55 M | |||
| Shares Owned By Insiders | 21.02 % | |||
| Shares Owned By Institutions | 7.17 % | |||
| Price To Sales | 10.84 X | |||
| Revenue | 36.83 B | |||
| Gross Profit | 9.76 B | |||
| EBITDA | (14.76 B) | |||
| Net Income | (48.56 B) | |||
| Cash And Equivalents | 27.8 B | |||
| Cash Per Share | 687.14 X | |||
| Total Debt | 40.79 B | |||
| Debt To Equity | 31.90 % | |||
| Current Ratio | 2.26 X | |||
| Book Value Per Share | 3,270 X | |||
| Cash Flow From Operations | (12.75 B) | |||
| Earnings Per Share | (1,283) X | |||
| Target Price | 121750.0 | |||
| Number Of Employees | 123 | |||
| Beta | 0.88 | |||
| Market Capitalization | 318.55 B | |||
| Total Asset | 636.86 B | |||
| Retained Earnings | (28.44 B) | |||
| Working Capital | 6.5 B | |||
| Current Asset | 11.66 B | |||
| Current Liabilities | 5.16 B | |||
| Z Score | 4.2 | |||
| Net Asset | 636.86 B |
About Genexine Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Genexine's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Genexine using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Genexine based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with Genexine
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Genexine position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Genexine will appreciate offsetting losses from the drop in the long position's value.The ability to find closely correlated positions to Genexine could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Genexine when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Genexine - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Genexine to buy it.
The correlation of Genexine is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Genexine moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Genexine moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Genexine can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Other Information on Investing in Genexine Stock
Genexine financial ratios help investors to determine whether Genexine Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Genexine with respect to the benefits of owning Genexine security.